DCMM
JAZZ icon

DG Capital Management (Massachusetts)’s Jazz Pharmaceuticals JAZZ Stock Holding History

DG Capital Management (Massachusetts)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-19,132
Closed -$2.54M – 63
2015
Q3 		$2.54M Buy
19,132
+4,001
+26% +$689K 1.71% 23
2015
Q2 		$2.66M Buy
15,131
+1,635
+12% +$294K 1.61% 30
2015
Q1 		$2.33M Buy
+13,496
New +$2.32M 1.4% 39

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

DG Capital Management (Massachusetts)'s JAZZ Position: Q4 2015 in Review

DG Capital Management (Massachusetts) sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 19,132 shares — an estimated $2.54M sold.

DG Capital Management (Massachusetts) first reported a position in JAZZ in Q1 2015 and held it in 3 quarters. The position peaked at $2.66M in Q2 2015. 345 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

  • DG Capital Management (Massachusetts) reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • DG Capital Management (Massachusetts) sold 19,132 Jazz Pharmaceuticals shares in Q4 2015, an estimated $2.54M.
  • DG Capital Management (Massachusetts) first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • DG Capital Management (Massachusetts)'s Jazz Pharmaceuticals position peaked at $2.66M in Q2 2015.
  • 345 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q4 2015, filed 9 Feb 2016.